Product Images Arnuity Ellipta
View Photos of Packaging, Labels & Appearance
- fluticasone furoate chemical structure - arnuityellipta spl graphic 01
- Figure 1. Impact of Intrinsic Factors on the Pharmacokinetics (PK) of Fluticasone Furoate (FF) - arnuityellipta spl graphic 02
- Figure 2. Impact of Coadministered Ketoconazolea on the Pharmacokinetics (PK) of Fluticasone Furoate - arnuityellipta spl graphic 03
- Figure 3. Dose-Ranging Trials - arnuityellipta spl graphic 04
- Figure 4. Mean Change from Baseline in Individual Serial FEV1 (mL) Assessments after 12 Weeks of Treatment – Trial 2 - arnuityellipta spl graphic 05
- Figure 5. Mean Change from Baseline in Trough FEV1 (mL) over Time – Trial 3 - arnuityellipta spl graphic 06
- Figure 6. Mean Change from Baseline in Individual Serial FEV1 (mL) Assessments after 24 Weeks of Treatment – Trial 4 - arnuityellipta spl graphic 07
- Parts figure - arnuityellipta spl graphic 08
- PIL Figure A - arnuityellipta spl graphic 09
- PIL Figure B - arnuityellipta spl graphic 10
- PIL Figure C - arnuityellipta spl graphic 11
- PIL Figure D - arnuityellipta spl graphic 12
- PIL Figure E - arnuityellipta spl graphic 13
- PIL Figure F - arnuityellipta spl graphic 14
- PIL Figure G - arnuityellipta spl graphic 15
- PIL Figure H - arnuityellipta spl graphic 16
- PIL Figure I - arnuityellipta spl graphic 17
- PIL Figure J - arnuityellipta spl graphic 18
- PIL Figure K - arnuityellipta spl graphic 19
- PIL Figure L - arnuityellipta spl graphic 20
- Arnuity Ellipta 100mcg 30 count carton - arnuityellipta spl graphic 21
- Arnuity Ellipta 200mcg 30 count carton - arnuityellipta spl graphic 22
- arnuityellipta spl graphic 23
Product Label Images
The following 23 images provide visual information about the product associated with Arnuity Ellipta NDC 0173-0876 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fluticasone furoate chemical structure - arnuityellipta spl graphic 01
Figure 1. Impact of Intrinsic Factors on the Pharmacokinetics (PK) of Fluticasone Furoate (FF) - arnuityellipta spl graphic 02
Figure 2. Impact of Coadministered Ketoconazolea on the Pharmacokinetics (PK) of Fluticasone Furoate - arnuityellipta spl graphic 03
This text seems to be a table displaying the impact of extrinsic factors on Fluticasone Furoate PK (pharmacokinetics) with respect to an interacting drug. The table lists fold changes and 90% confidence intervals of Fluticasone Furoate's area under the curve (AuC) and maximum concentration (Cmax) in response to different dosages of the interacting drug. The only drug mentioned here is "Ketoconazole" which seems to reduce Fluticasone Furoate's AuC and Cmax. The table recommends caution while prescribing Fluticasone Furoate in conjunction with Ketoconazole.*
Figure 3. Dose-Ranging Trials - arnuityellipta spl graphic 04
Figure 4. Mean Change from Baseline in Individual Serial FEV1 (mL) Assessments after 12 Weeks of Treatment – Trial 2 - arnuityellipta spl graphic 05
This is a table displaying LS Mean Change from Baseline (measured in mL) and Planned Time since Dose (measured in hours) for ARNUITY ELLIPTA 100 mcg once daily and Placebo. The values for LS Mean Change from Baseline are 70, 500, 0, 300, 20, and 100. The values for Planned Time since Dose are not specified.*
Figure 5. Mean Change from Baseline in Trough FEV1 (mL) over Time – Trial 3 - arnuityellipta spl graphic 06
Figure 6. Mean Change from Baseline in Individual Serial FEV1 (mL) Assessments after 24 Weeks of Treatment – Trial 4 - arnuityellipta spl graphic 07
Parts figure - arnuityellipta spl graphic 08
PIL Figure A - arnuityellipta spl graphic 09
PIL Figure B - arnuityellipta spl graphic 10
PIL Figure C - arnuityellipta spl graphic 11
PIL Figure D - arnuityellipta spl graphic 12
PIL Figure E - arnuityellipta spl graphic 13
PIL Figure F - arnuityellipta spl graphic 14
PIL Figure G - arnuityellipta spl graphic 15
PIL Figure H - arnuityellipta spl graphic 16
PIL Figure I - arnuityellipta spl graphic 17
PIL Figure J - arnuityellipta spl graphic 18
PIL Figure K - arnuityellipta spl graphic 19
PIL Figure L - arnuityellipta spl graphic 20
Arnuity Ellipta 100mcg 30 count carton - arnuityellipta spl graphic 21
This is a medication called Arnuity Ellipta, which is a powder that is inhaled orally for treating breathing problems. Each blister pack contains 50mcg of the active ingredient, Fluticasone Furoate, along with lactose monohydrate. The National Drug Code (NDC) for this medication is 0173-0888-10.*
Arnuity Ellipta 200mcg 30 count carton - arnuityellipta spl graphic 22
The text describes a medication called ANNUITY ELLIPTA, with the NDC code of 0173-0874-10. It is a prescription medication that contains fluticasone furoate inhalation powder and lactose monohydrate, which is used for oral inhalation only. Each blister pack contains 100 micrograms of the medication.*
arnuityellipta spl graphic 23
This text is a label for medication. The medication is called "Fluticasone Furoate Inhalation Powder" and comes in a package with the trade name "N UITY ELLIPTA". It is intended for oral inhalation only and contains 200 mcg of fluticasone furoate and lactose monohydrate per blister. The package is only available with a prescription (Rx Only).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
